These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Elmarakby AA; Quigley JE; Pollock DM; Imig JD Hypertension; 2006 Mar; 47(3):557-62. PubMed ID: 16415373 [TBL] [Abstract][Full Text] [Related]
3. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. Ndisang JF; Jadhav A J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817 [TBL] [Abstract][Full Text] [Related]
4. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Wang Y; Wang DH Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732 [TBL] [Abstract][Full Text] [Related]
6. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats. Kimura K; Ohkita M; Koyama M; Matsumura Y Life Sci; 2012 Oct; 91(13-14):644-50. PubMed ID: 22569294 [TBL] [Abstract][Full Text] [Related]
7. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension. Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137 [TBL] [Abstract][Full Text] [Related]
9. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension. Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566 [TBL] [Abstract][Full Text] [Related]
11. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758 [TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice. Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663 [TBL] [Abstract][Full Text] [Related]
14. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats. Ndisang JF; Jadhav A Hypertens Res; 2010 Apr; 33(4):338-47. PubMed ID: 20203687 [TBL] [Abstract][Full Text] [Related]
15. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway. Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237 [TBL] [Abstract][Full Text] [Related]
16. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats. Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S Food Funct; 2015 Jul; 6(7):2179-2186. PubMed ID: 26011796 [TBL] [Abstract][Full Text] [Related]
17. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Allcock GH; Venema RC; Pollock DM Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985 [TBL] [Abstract][Full Text] [Related]
18. Renal Inflammation in DOCA-Salt Hypertension. Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356 [TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats. Bae EH; Kim IJ; Park JW; Ma SK; Lee JU; Kim SW Nephrol Dial Transplant; 2010 Apr; 25(4):1051-9. PubMed ID: 19948880 [TBL] [Abstract][Full Text] [Related]
20. Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats. Guan Z; Singletary ST; Cha H; Van Beusecum JP; Cook AK; Pollock JS; Pollock DM; Inscho EW Am J Physiol Renal Physiol; 2016 Mar; 310(6):F456-65. PubMed ID: 26697978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]